Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioceres Crop Solutions (BIOX) Operating Income (2017 - 2025)

Historic Operating Income for Bioceres Crop Solutions (BIOX) over the last 9 years, with Q3 2025 value amounting to $7.2 million.

  • Bioceres Crop Solutions' Operating Income rose 20429.47% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 9729.82%. This contributed to the annual value of -$2.2 million for FY2025, which is 10487.64% down from last year.
  • As of Q3 2025, Bioceres Crop Solutions' Operating Income stood at $7.2 million, which was up 20429.47% from -$14.9 million recorded in Q2 2025.
  • Bioceres Crop Solutions' 5-year Operating Income high stood at $29.9 million for Q1 2023, and its period low was -$14.9 million during Q2 2025.
  • Moreover, its 5-year median value for Operating Income was $7.9 million (2024), whereas its average is $8.5 million.
  • Its Operating Income has fluctuated over the past 5 years, first surged by 129079.61% in 2023, then crashed by 24190.48% in 2025.
  • Over the past 5 years, Bioceres Crop Solutions' Operating Income (Quarter) stood at $17.7 million in 2021, then crashed by 87.46% to $2.2 million in 2022, then soared by 659.0% to $16.8 million in 2023, then tumbled by 52.98% to $7.9 million in 2024, then fell by 8.98% to $7.2 million in 2025.
  • Its Operating Income stands at $7.2 million for Q3 2025, versus -$14.9 million for Q2 2025 and $933210.0 for Q1 2025.